Supplementary Figure 2
Enhanced Ca 2+ signaling of mIgG-BCRs requires Grb2. Splenic B cells of wild type C57BL/6J mice (B, wt) or Grb2 fl/fl mb1 cre/+ mice (C & D, Grb2 -/-) were retrovirally transfected to express either wild type (wt, blue lines) or tyrosine to phenylalanine-mutant (YF, red lines) mIgG2a-BCRs along with IRES-driven EGFP (A). Cells were stimulated with anti-IgG (B & C) or anti-IgM (D) F(abˈ) 2 fragments (20 mg per ml each) and Ca 2+ mobilization was recorded in the presence of 1 mM extracellular CaCl 2 . Data are representative of five independent experiments.
Supplementary Figure 3
Generation of GRB2-deficient DG75 cells. (A) Two targeting vectors for the two alleles of GRB2 were generated containing either a blasticidin (bsr) or histidinol (his) resistance cassette, respectively, that replaced parts of exon 2 and in addition introduced a STOP mutation at codon four of the Grb2 open reading frame (E2*), followed by a polyadenylation signal sequence (pA). Furthermore, the targeting vectors contained a diphetria toxin alpha (DTA) cassette from which the toxin is produced if the targeting vectors integrate randomly in the genome. Screening of cells for homologous recombination was done by PCR (data not shown). (B) Western blot analysis of Grb2 expression in wild type (wt) and GRB2-deficient (GRB2-ko) DG75 cells. 
Supplementary Figure 4

Supplementary Figure 9
Uncropped western blots shown in Figure 6 . "XI" denotes a chimeric Grb2/GRAP SH3 domain (see Supplementary Figure 12 ). This lane is not shown in Figure 6 as it was not relevant there.
Supplementary Figure 10
Generation of BTK-deficient DG75 cells. DG75 Burkitt lymphoma cells were obtained from a boy with a primary abdominal lymphoma. Since in humans the BTK gene is located on the X chromosome, DG75 cells contain only a single copy of that gene. (A) Targeting strategy of human BTK gene. The targeting vector contained a loxP siteflanked puromycin (puro) resistance cassette that replaced parts of exon 2 and the entire exon 3 of the BTK gene. In addition a STOP mutation was introduced at the eighth codon of the open reading frame in exon 2 (E2*). After successful homologous recombination, cells were transiently transfected with an expression vector for the Cre recombinase to allow for excision of the puromycin resistance cassette. Eventually, the modified BTK locus contained a truncated, mutant exon 2 and a remnant loxP site. (B) Western blot analysis of Btk expression in wild type (wt) and BTK-deficient (BTK-ko) DG75 cells. 
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